Synthesis of Pyridopyrazine-1,6-dione γ-Secretase Modulators via Selective 4-Methylimidazole N1-Buchwald Arylation.

An efficient synthesis of pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) is described. Our route features the construction of a crystalline lactone intermediate via a selective palladium-catalyzed 4-methylimidazole N1-arylation using the Buchwald Xantphos Pd G4 precatalyst, which does not require a preactivation step. The weak inorganic base KHCO3 was employed to minimize saponification of a particularly sensitive lactone substrate. Additional key transformations include DABAL-Me3-mediated lactone aminolysis and a mild TBD/ethyl trifluoroacetate mediated lactam ring closure to afford a representative GSM in high yield.

[1]  Christopher W. am Ende,et al.  Protocol for the Direct Conversion of Lactones to Lactams Mediated by 1,5,7-Triazabicyclo[4.4.0]dec-5-ene: Synthesis of Pyridopyrazine-1,6-diones. , 2017, The Journal of organic chemistry.

[2]  Thomas Mcinally,et al.  Investigating Scale-Up and Further Applications of DABAL-Me3 Promoted Amide Synthesis , 2015 .

[3]  Gregory W. Kauffman,et al.  Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability. , 2015, ACS medicinal chemistry letters.

[4]  Gregory W. Kauffman,et al.  Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin. , 2015, Bioorganic & medicinal chemistry letters.

[5]  D. Irvine,et al.  On DABAL-Me3 promoted formation of amides , 2013 .

[6]  Gregory W. Kauffman,et al.  Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012 , 2013, Expert opinion on therapeutic patents.

[7]  Christopher W. am Ende,et al.  Synthesis of pyridopyrazine-1,6-diones from 6-hydroxypicolinic acids via a one-pot coupling/cyclization reaction. , 2013, Organic letters.

[8]  Gregory W. Kauffman,et al.  Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators. , 2012, Bioorganic & medicinal chemistry letters.

[9]  S. Buchwald,et al.  Completely N1-selective palladium-catalyzed arylation of unsymmetric imidazoles: application to the synthesis of nilotinib. , 2012, Journal of the American Chemical Society.

[10]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[11]  Alzheimer’s Association,et al.  2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.

[12]  S. Woodward Design versus Discovery in Synthetic Applications of Organoalanes , 2007 .

[13]  S. Woodward,et al.  Amide bond formation using an air-stable source of AlMe3 , 2006 .

[14]  K. Wehrstedt,et al.  Explosive properties of 1-hydroxybenzotriazoles. , 2005, Journal of hazardous materials.

[15]  Rong Wang,et al.  A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.

[16]  Martin Pettersson,et al.  γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease , 2017 .